OVIT (OncoVista Innovative Therapies) Market Cap: $0.00 Mil (As of Jun. 27, 2026)


What is OncoVista Innovative Therapies Market Cap?

OncoVista Innovative Therapies OVIT Market Cap is $0.00 Mil as of Jun. 27, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). OncoVista Innovative Therapies's share price for the quarter that ended in Sep. 2015 was $0.4199. OncoVista Innovative Therapies's Shares Outstanding (EOP) for the quarter that ended in Sep. 2015 was 23.56 Mil. Therefore, OncoVista Innovative Therapies's market cap for the quarter that ended in Sep. 2015 was $9.89 Mil.

OncoVista Innovative Therapies's quarterly market cap increased from Mar. 2015 ($9.91 Mil) to Jun. 2015 ($20.25 Mil) but then declined from Jun. 2015 ($20.25 Mil) to Sep. 2015 ($9.89 Mil).

OncoVista Innovative Therapies's annual market cap declined from Dec. 2012 ($2.81 Mil) to Dec. 2013 ($1.08 Mil) but then increased from Dec. 2013 ($1.08 Mil) to Dec. 2014 ($1.32 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. OncoVista Innovative Therapies's Enterprise Value for Today is $0.00 Mil.

OncoVista Innovative Therapies  (OTCPK:OVIT) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

OncoVista Innovative Therapies Market Cap Related Terms

OncoVista Innovative Therapies Market Cap Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Market Cap Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.98 7.48 2.81 1.08 1.32

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.19 1.32 9.91 20.25 9.89

OVIT vs RSPI, HSTC, CAPS: Market Cap Comparison

For the Biotechnology subindustry, OncoVista Innovative Therapies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoVista Innovative Therapies Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's Market Cap distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's Market Cap falls into.


OncoVista Innovative Therapies Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

OncoVista Innovative Therapies's Market Cap for the fiscal year that ended in Dec. 2014 is calculated as

Market Cap (A: Dec. 2014 )=Share Price (A: Dec. 2014 )*Shares Outstanding (EOP) (A: Dec. 2014 )
=$0.06*22.013
=$1.32

OncoVista Innovative Therapies's Market Cap for the quarter that ended in Sep. 2015 is calculated as

Market Cap (Q: Sep. 2015 )=Share Price (Q: Sep. 2015 )*Shares Outstanding (EOP) (Q: Sep. 2015 )
=$0.4199*23.559
=$9.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.00 Mil mean?
OncoVista Innovative Therapies (OVIT) has a Market Cap of $0.00 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Market Cap too high?
OncoVista Innovative Therapies' current Market Cap is $0.00 Mil.
How does OncoVista Innovative Therapies' Market Cap compare to RSPI and HSTC?
OncoVista Innovative Therapies' Market Cap of $0.00 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 113.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on OncoVista Innovative Therapies and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OncoVista Innovative Therapies's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Market Cap is $0.00 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.